Clinical Research Directory
Browse clinical research sites, groups, and studies.
The ProCaRis Study: Prostate Cancer Risk Assessment in General Practice
Sponsor: University of Aarhus
Summary
The preferred method for early detection of prostate cancer (PCa) in older men with family history is the Prostate Specific Antigen test (PSA test), although the method is imprecise. It produces a high number of false-positive results and increases the risk of over-diagnosis and over-treatment. Yet, an increasing number of men get the PSA test as part of unsystematic screening. Genetic risk assessment may be a better way to identify men with low risk of PCa. The main study hypothesis is that genetic information about low risk of PCa can reduce the number of patients who get a PSA test as part of unsystematic screening.
Official title: Prostate Cancer Risk Assessment Using Genetic Markers in General Practice
Key Details
Gender
MALE
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
5000
Start Date
2013-02
Completion Date
2031-10-30
Last Updated
2023-12-04
Healthy Volunteers
Yes
Conditions
Interventions
Genetic risk assessment
Locations (1)
Department of Molecular Medicine
Aarhus N, Aarhus, Denmark